DEP always first

Over the last few years many holders on this site said they bought because of the dendrimers ability to take black box and generic cancer treatments and remove side effects while improving efficacy. What has changed? now it's all about vivagel and mgt I imagine the CEO and board were shocked when they got the reply from the fda, my hope is the shutdown was partly to blame and it gets sorted out. In the meantime the reason I bought is still on course have we forgot the $ 7BILLION sales that dep/dox will be competing for with a suprior drug and all the other patents we have for other big selling drugs. One licence sale for cancer treatment say dep/dox and all will be forgiven and heading for AB's $5. Some on this forum who have sold out continue to add negative diatribes to the conversation me I am holding on the sky is not falling i o